Tibra Equities Europe’s Lunai Bioworks LNAI Stock Holding History

Tibra Equities Europe’s Portfolio LNAI Stock Details LNAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-524	Closed	-$208K	–	160
2021 Q2	$208K	Buy	+524	New	+$171K	0.06%	236

Other funds holding LNAI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tibra Equities Europe's LNAI Position: Q3 2021 in Review

Tibra Equities Europe sold out of Lunai Bioworks (LNAI) in Q3 2021, closing a stake of 524 shares — an estimated $208K sold.

Tibra Equities Europe first reported a position in LNAI in Q2 2021 and held it in 1 quarter. The position peaked at $208K in Q2 2021. 32 funds tracked by Wall St. Rank hold LNAI as of Q3 2021.

Tibra Equities Europe reported no remaining Lunai Bioworks position as of Q3 2021 after selling out during the quarter.
Tibra Equities Europe sold 524 Lunai Bioworks shares in Q3 2021, an estimated $208K.
Tibra Equities Europe first reported a position in Lunai Bioworks in Q2 2021 and held it in 1 quarter.
Tibra Equities Europe's Lunai Bioworks position peaked at $208K in Q2 2021.
32 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.